FAQ/Help |
Calendar |
Search |
Today's Posts |
08-05-2011, 07:29 AM | #1 | ||
|
|||
Member
|
Oxford BioMedica Announces Interim Data from Highest (5x) Dose Cohort in ProSavin Phase I/II Study in Parkinson's Disease
http://neurotalk.psychcentral.com/sh...895#post792895 |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
ProSavin® for the treatment of Parkinson’s disease (PD) | Parkinson's Disease Clinical Trials | |||
ProSavin phase I/II study in Parkinson's disease | Parkinson's Disease | |||
ND0611, a new patch for the treatment of Parkinson's disease | Parkinson's Disease | |||
Hope For New Parkinson's Disease Treatment Through RXR Activation | Parkinson's Disease | |||
Treatment Modalities for Parkinson's Disease | Parkinson's Disease |